Reply: Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient

Nicole J Van Bergen^{1

2}, Adhish S Walvekar³, Carole L Linster³, John Christodoulou^{1

2

3

4}

Affiliations

¹ Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Australia.
² Department of Paediatrics, University of Melbourne, Melbourne, Australia.
³ Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux L-4367, Luxembourg.
⁴ Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, VIC, Australia.

Editorial

Nicole J Van Bergen et al. Brain. 2022.

. 2022 Jun 3;145(5):e41-e42.

doi: 10.1093/brain/awac066.

Nicole J Van Bergen^{1

2}, Adhish S Walvekar³, Carole L Linster³, John Christodoulou^{1

2

3

4}

¹ Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Australia.
² Department of Paediatrics, University of Melbourne, Melbourne, Australia.
³ Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux L-4367, Luxembourg.
⁴ Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, VIC, Australia.

No abstract available

Comment in

Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient.
Manor J, Calame DG, Gijavanekar C, Tran A, Fatih JM, Lalani SR, Mizerik E, Parnes M, Mehta VP, Adesina AM, Lupski JR, Scaglia F, Elsea SH. Manor J, et al. Brain. 2022 Jun 3;145(5):e36-e40. doi: 10.1093/brain/awac065. Brain. 2022. PMID: 35231119 No abstract available.

Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient.
Manor J, Calame DG, Gijavanekar C, Tran A, Fatih JM, Lalani SR, Mizerik E, Parnes M, Mehta VP, Adesina AM, Lupski JR, Scaglia F, Elsea SH. Manor J, et al. Brain. 2022 Jun 3;145(5):e36-e40. doi: 10.1093/brain/awac065. Brain. 2022. PMID: 35231119 No abstract available.